• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中代谢基因和代谢物的改变。

Alterations of metabolic genes and metabolites in cancer.

机构信息

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

出版信息

Semin Cell Dev Biol. 2012 Jun;23(4):370-80. doi: 10.1016/j.semcdb.2012.01.013. Epub 2012 Jan 28.

DOI:10.1016/j.semcdb.2012.01.013
PMID:22306135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3351496/
Abstract

Altered metabolic regulation has long been observed in human cancer and broadly used in the clinic for tumor detection. Two recent findings--the direct regulation of metabolic enzymes by frequently mutated cancer genes and frequent mutations of several metabolic enzymes themselves in cancer--have renewed interest in cancer metabolism. Supporting a causative role of altered metabolic enzymes in tumorigenesis, abnormal levels of several metabolites have been found to play a direct role in cancer development. The alteration of metabolic genes and metabolites offer not only new biomarkers for diagnosis and prognosis, but also potential new targets for cancer therapy.

摘要

代谢调控异常在人类癌症中很早就被观察到,并广泛应用于肿瘤检测的临床实践中。最近的两项发现——经常发生突变的癌症基因对代谢酶的直接调控以及癌症中几个代谢酶自身的频繁突变——重新激发了人们对癌症代谢的兴趣。代谢酶的异常水平被发现直接参与肿瘤的发生,从而为代谢酶在肿瘤发生中的因果作用提供了支持。代谢基因和代谢物的改变不仅为诊断和预后提供了新的生物标志物,而且为癌症治疗提供了新的潜在靶点。

相似文献

1
Alterations of metabolic genes and metabolites in cancer.癌症中代谢基因和代谢物的改变。
Semin Cell Dev Biol. 2012 Jun;23(4):370-80. doi: 10.1016/j.semcdb.2012.01.013. Epub 2012 Jan 28.
2
Glutamine reliance in cell metabolism.谷氨酰胺在细胞代谢中的依赖性。
Exp Mol Med. 2020 Sep;52(9):1496-1516. doi: 10.1038/s12276-020-00504-8. Epub 2020 Sep 17.
3
Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.癌症中的代谢重编程:解析谷氨酰胺在肿瘤发生中的作用。
Semin Cell Dev Biol. 2012 Jun;23(4):362-9. doi: 10.1016/j.semcdb.2012.02.002. Epub 2012 Feb 11.
4
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.致癌性 K-Ras 将葡萄糖和谷氨酰胺代谢解偶联,以支持癌细胞生长。
Mol Syst Biol. 2011 Aug 16;7:523. doi: 10.1038/msb.2011.56.
5
Multiple metabolic alterations exist in mutant PI3K cancers, but only glucose is essential as a nutrient source.突变型 PI3K 癌症存在多种代谢改变,但只有葡萄糖是必需的营养来源。
PLoS One. 2012;7(9):e45061. doi: 10.1371/journal.pone.0045061. Epub 2012 Sep 13.
6
Oncometabolites: linking altered metabolism with cancer.代谢物:将代谢改变与癌症联系起来。
J Clin Invest. 2013 Sep;123(9):3652-8. doi: 10.1172/JCI67228. Epub 2013 Sep 3.
7
LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.LKB1 缺失诱导的肿瘤发生和非肿瘤性疾病中的代谢重编程。
Mol Metab. 2021 Feb;44:101131. doi: 10.1016/j.molmet.2020.101131. Epub 2020 Dec 3.
8
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.基因组改变是与肿瘤缺氧相关的泛癌代谢转变的基础。
Genome Biol. 2016 Jun 29;17(1):140. doi: 10.1186/s13059-016-0999-8.
9
The Emerging Hallmarks of Cancer Metabolism.癌症代谢的新特征
Cell Metab. 2016 Jan 12;23(1):27-47. doi: 10.1016/j.cmet.2015.12.006.
10
MYC-induced cancer cell energy metabolism and therapeutic opportunities.MYC诱导的癌细胞能量代谢及治疗机会。
Clin Cancer Res. 2009 Nov 1;15(21):6479-83. doi: 10.1158/1078-0432.CCR-09-0889. Epub 2009 Oct 27.

引用本文的文献

1
Omics Integration Uncovers Mechanisms Associated with HIV Viral Load and Potential Therapeutic Insights.组学整合揭示与HIV病毒载量相关的机制及潜在治疗见解。
medRxiv. 2025 Jul 30:2025.07.29.25332397. doi: 10.1101/2025.07.29.25332397.
2
KDM6A downregulation promotes tumor-prone cytokines expression in cancer-associated fibroblasts by activating enhancers.KDM6A下调通过激活增强子促进癌症相关成纤维细胞中促肿瘤细胞因子的表达。
Cell Death Dis. 2025 Jul 14;16(1):523. doi: 10.1038/s41419-025-07818-3.
3
Development and validation of a prognostic model for predicting survival and immunotherapy benefits in melanoma based on metabolism-relevant genes.

本文引用的文献

1
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.IDH2 突变在血管免疫母细胞性 T 细胞淋巴瘤中很常见。
Blood. 2012 Feb 23;119(8):1901-3. doi: 10.1182/blood-2011-11-391748. Epub 2012 Jan 3.
2
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.通过广泛的肿瘤基因分型鉴定出胆管癌中异柠檬酸脱氢酶 (IDH)1 和 IDH2 的频繁突变。
Oncologist. 2012;17(1):72-9. doi: 10.1634/theoncologist.2011-0386. Epub 2011 Dec 16.
3
Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.
基于代谢相关基因的黑色素瘤生存及免疫治疗获益预测模型的构建与验证
Discov Oncol. 2025 Jul 12;16(1):1321. doi: 10.1007/s12672-025-03186-8.
4
Pathway metabolite ratios reveal distinctive glutamine metabolism in a subset of proliferating cells.代谢途径代谢物比率揭示了增殖细胞亚群中独特的谷氨酰胺代谢。
Mol Syst Biol. 2025 Jun 5. doi: 10.1038/s44320-025-00099-0.
5
Construction and evaluation of a prognostic model based on the expression of the metabolism-related signatures in patients with osteosarcoma.基于骨肉瘤患者代谢相关标志物表达的预后模型构建与评估
BMC Musculoskelet Disord. 2025 Mar 27;26(1):303. doi: 10.1186/s12891-025-08439-9.
6
Identifying High-Quality Leads among Screened Anticancerous Compounds Using SMILES Representations.使用SMILES表示法在筛选出的抗癌化合物中识别高质量先导化合物。
ACS Omega. 2024 Jun 28;9(28):30645-30653. doi: 10.1021/acsomega.4c02801. eCollection 2024 Jul 16.
7
The Noncanonical Functions of Metabolites in Tumor Progression.代谢物在肿瘤进展中的非经典功能
Metabolites. 2024 Mar 19;14(3):171. doi: 10.3390/metabo14030171.
8
Electrochemical Nanoreactor Provides a Comprehensive View of Isocitrate Dehydrogenase Cancer-drug Kinetics.电化学纳米反应器提供了异柠檬酸脱氢酶癌症药物动力学的全面视图。
Angew Chem Weinheim Bergstr Ger. 2023 Oct 16;135(42):e202309149. doi: 10.1002/ange.202309149. Epub 2023 Sep 12.
9
Unveiling Disrupted Lipid Metabolism in Benign Prostate Hyperplasia, Prostate Cancer, and Metastatic Patients: Insights from a Colombian Nested Case-Control Study.揭示良性前列腺增生、前列腺癌和转移患者中脂质代谢紊乱:来自哥伦比亚巢式病例对照研究的见解
Cancers (Basel). 2023 Nov 18;15(22):5465. doi: 10.3390/cancers15225465.
10
Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies.代谢干预联合 CTLA-4 和 PD-1/PD-L1 阻断治疗肿瘤:机制与策略。
Front Med. 2023 Oct;17(5):805-822. doi: 10.1007/s11684-023-1025-7. Epub 2023 Oct 28.
奥里耶病和马富西综合征是由 IDH1 和 IDH2 的体细胞镶嵌突变引起的。
Nat Genet. 2011 Nov 6;43(12):1262-5. doi: 10.1038/ng.994.
4
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.体细胞镶嵌性 IDH1 和 IDH2 突变与 Ollier 病和 Maffucci 综合征中的软骨瘤和梭形细胞血管瘤有关。
Nat Genet. 2011 Nov 6;43(12):1256-61. doi: 10.1038/ng.1004.
5
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.核 PKM2 在 EGFR 激活时调节β-连环蛋白的转录激活。
Nature. 2011 Dec 1;480(7375):118-22. doi: 10.1038/nature10598.
6
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.使用磁共振波谱技术无创检测 IDH1 突变型脑胶质瘤患者的 2-羟戊二酸和其他代谢物。
J Neurooncol. 2012 Mar;107(1):197-205. doi: 10.1007/s11060-011-0737-8. Epub 2011 Oct 21.
7
Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.Fh1 缺陷型小鼠肾囊肿的形成不依赖于 Hif/Phd 通路:富马酸盐在 KEAP1 琥珀酰化和 Nrf2 信号中的作用。
Cancer Cell. 2011 Oct 18;20(4):524-37. doi: 10.1016/j.ccr.2011.09.006.
8
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma.遗传性和散发性 2 型乳头状肾细胞癌之间存在抗氧化反应表型。
Cancer Cell. 2011 Oct 18;20(4):511-23. doi: 10.1016/j.ccr.2011.08.024.
9
N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.核 RNA 中的 N6-甲基腺苷是肥胖相关 FTO 的主要底物。
Nat Chem Biol. 2011 Oct 16;7(12):885-7. doi: 10.1038/nchembio.687.
10
Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production.鉴定与代谢物 R(-)-2-羟基戊二酸产生相关的其他 IDH 突变。
Oncogene. 2012 May 10;31(19):2491-8. doi: 10.1038/onc.2011.416. Epub 2011 Sep 26.